Company: PCRX
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001628280-25-050176
Chunk: 195

Company: Pacira BioSciences, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 195
---
 frequent to be considered a Level 1 input or that of comparable securities. The fair value of U.S. government bonds is based on level 1 trading activity. At the time of purchase, all available-for-sale investments had an “A” or better rating by Standard & Poor’s. The following summarizes the Company’s short-term available-for-sale investments at September 30, 2025 and December 31, 2024 (in thousands):September 30, 2025 InvestmentsCostGrossUnrealizedGainsGrossUnrealizedLossesFair Value(Level 2)Current:Asset-backed securities$8,520 $2 $— $8,522 Commercial paper57,292 8 (9)57,291 Corporate bonds32,918 16 (2)32,932           Total$98,730 $26 $(11)$98,745 December 31, 2024 InvestmentsCostGrossUnrealizedGainsGrossUnrealizedLossesFair Value(Level 2)Current:Asset-backed securities$21,626 $43 $— $21,669 Commercial paper142,556 120 (55)142,621 Corporate bonds32,502 25 (5)32,522 U.S. federal agency bonds5,996 8 — 6,004 Yankee bond5,012 13 — 5,025           Total$207,692 $209 $(60)$207,841 At September 30, 2025, there were no investments available for sale that were materially less than their amortized cost.

Pacira BioSciences, Inc.  |  Q3 2025 Form 10-Q  |  24

The Company elects to recognize its interest receivable separate from its available-for-sale investments. At September 30, 2025 and December 31, 2024, the interest receivable from its available-for-sale investments recognized in prepaid expenses and other current assets was $0.2 million and $0.5 million, respectively.Credit RiskFinancial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term and long-term available-for-sale investments and accounts receivable. The Company maintains its cash and cash equivalents with high-credit quality financial institutions. Such amounts may exceed federally-insured limits. As of September 30